CDKN2D, cyclin dependent kinase inhibitor 2D, 1032

N. diseases: 110; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0206664
Disease: Teratocarcinoma
Teratocarcinoma
0.050 Biomarker disease BEFREE Similar to iPSC, P19 teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types. 31353083 2019
CUI: C0206664
Disease: Teratocarcinoma
Teratocarcinoma
0.050 Biomarker disease BEFREE To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human). 29207191 2018
CUI: C0206664
Disease: Teratocarcinoma
Teratocarcinoma
0.050 Biomarker disease BEFREE Overexpression of Cathepsin E Interferes with Neuronal Differentiation of P19 Embryonal Teratocarcinoma Cells by Degradation of N-cadherin. 27116544 2017
CUI: C0206664
Disease: Teratocarcinoma
Teratocarcinoma
0.050 Biomarker disease BEFREE Using P19 teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage. 16012770 2005
CUI: C0206664
Disease: Teratocarcinoma
Teratocarcinoma
0.050 Biomarker disease BEFREE Synaptophysin and synapsin I, another synaptic vesicle protein, are also expressed by retinoic acid-induced neuronally differentiated P19 teratocarcinoma cells. 12492469 2003